To study ciprofloxacin pharmacokinetics in patients who are critically ill and undergoing continuous dialysis

Completed

• Conditions: Patients on dialysis; Nutritional, Metabolic, Endocrine; Renal failure

• Registration Number: ISRCTN52722850
• Lead Sponsor: Trinity College Dublin (Ireland)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-05-19
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 7

Inclusion Criteria

1. Aged over 18
2. Requiring Continuous Veno Venous Hemodiafiltration (CVVHDF)
3. Requiring ciprofloxacin therapy

Exclusion Criteria

1. Aged less than 18
2. Patient / relative consent denied

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To obtain reliable estimates of ciprofloxacin pharmacokinetic parameters for patients in intensive care unit (ICU) on Continuous veno-venous hemodiafiltration (CVVHDF)

Secondary Outcome Measures

Name	Time	Method
To describe achieved pharmacodynamic parameters in these patients